The Novel Functions of cGMP-Specific Phosphodiesterase 5 and its Inhibitors in Carcinoma Cells and Pulmonary/Cardiovascular Vessels

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-02 ,pp. : 437-454

Bentham Science Publishers

Access to resources Recommend Favorite

KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5

By Hirose R.   Okumura H.   Yoshimatsu A.   Irie J.   Onoda Y.   Nomoto Y.   Takai H.   Ohno T.   Ichimura M.  

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite

Ca 2+ /calmodulin-dependent cyclic GMP phosphodiesterase activity in granule neurons and astrocytes from rat cerebellum

By Agullo L.   Garca A.  

European Journal of Pharmacology, Vol. 323, Iss. 1, 1997-03 ,pp. : 119-125

Elsevier

Access to resources Recommend Favorite

Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy]quinolinone (CCT-62)

By Liao C.-H.   Tzeng C.-C.   Teng C.-M.  

European Journal of Pharmacology, Vol. 349, Iss. 1, 1998-05 ,pp. : 107-114

Elsevier

Access to resources Recommend Favorite

Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction

By Kendirci Muammer   Bivalacqua Trinity J   Hellstrom Wayne JG  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 923-932

Informa Healthcare

Access to resources Recommend Favorite